Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.43 |
| ▸ | EGFR | P00533 | 7/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.37 |
| ▸ | GPR6 | P46095 | 3/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.36 |
| ▸ | RET | P07949 | 2/20 | 0.36 |
| ▸ | EPHB2 | P29323 | 2/20 | 0.36 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.36 |
| ▸ | EPHA4 | P54764 | 2/20 | 0.36 |
| ▸ | RIPK3 | Q9Y572 | 2/20 | 0.36 |
| ▸ | GAK | O14976 | 1/20 | 0.36 |
| ▸ | LYN | P07948 | 1/20 | 0.36 |
| ▸ | EPHA1 | P21709 | 1/20 | 0.36 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.36 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.36 |
| ▸ | EPHA5 | P54756 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.36 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5822810 | 0.93 | GPR119 (0.45) | GPR119EGFRERBB2GPR6CYP2C9 | |
| SCHEMBL389661 | 0.90 | GPR119 (0.56) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3254476 | 0.86 | GPR119 (0.45) | GPR119ERBB2GPR6CYP2C9KCNH2 | |
| SCHEMBL14458861 | 0.83 | GPR119 (0.58) | GPR119CYP2C9KCNH2 | |
| SCHEMBL389581 | 0.82 | GPR119 (0.52) | GPR119EGFRCYP2C9KCNH2 | |
| SCHEMBL1068766 | 0.82 | EGFR (0.43) | EGFRERBB2GPR6KCNH2RIPK2 | |
| SCHEMBL390717 | 0.81 | GPR119 (0.53) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3154259 | 0.80 | GPR119 (0.68) | GPR119CYP2C9KCNH2 | |
| SCHEMBL5818269 | 0.79 | EGFR (0.44) | EGFRERBB2GPR6KCNH2RIPK2 | |
| SCHEMBL3867879 | 0.79 | SMN1; SMN2 (0.40) | GPR119EGFRERBB2CYP2C9KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2004157-A2 | USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AS WELL AS COMBINATION THERAPY RELATING THERETO | Arena Pharmaceuticals, Inc. (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007120702-A2 | USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-10-25 | — | — | WO | disclosed |
| EP-1732562-A2 | SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2006-12-20 | — | — | EP | disclosed |
| WO-2006083491-A2 | SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2006-08-10 | — | — | WO | disclosed |